The new test is designed to easily, non-invasively detect cancer from blood or biopsy tissue within ten minutes by analysing methyl group changes at a whole genome level.
Methyl groups, which are tiny molecules on DNA, were found to be significantly altered in cancer patients. The team observed that the methyl groups are spread out across the genome in healthy cells but were present only at specific places on cancer genomes.
